An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy

Oral Diseases

Volumn 19, Issue 5, 2013, Pages 456-464

  Khurana, H ^a   Pandey, R K ^a   Saksena, A K ^a   Kumar, A ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

ChiMES; ChROM; OMAS; Pycnogenol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CHLORHEXIDINE GLUCONATE; GLYCEROL; PYCNOGENOL; FLAVONOID; PYCNOGENOLS; VITAMIN;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL MUCOSITIS; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SINGLE BLIND PROCEDURE; WORLD HEALTH ORGANIZATION; CHEMICALLY INDUCED; COMPARATIVE STUDY; NEOPLASMS; STOMATITIS;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; FLAVONOIDS; HUMANS; MALE; NEOPLASMS; SINGLE-BLIND METHOD; STOMATITIS; VITAMIN E; VITAMINS;

EID: 84883821792     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12024     Document Type: Article

References (32)

1. Antunes HS, de Azevedo AM, da Silva Bouzas LF, et al. (2007). Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109: 2250-2255.
2. Belcaro G, Cesarone MR, Genovesi D et al (2008). Pycnogenol may alleviate adverse effects in oncologic treatment. Panminerva Med 50: 227-234.
3. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, Le Gall E (1998). Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 34: 1588-1591.
4. Brigelius-Flohe R, Traber MG (1999). Vitamin E: function and metabolism. FASEB J 13: 1145-1155.
5. Cheng KK, Chang AM, Yuen MP (2004). Prevention of oral mucositis in paediatric patients treated with chemotherapy: a randomised crossover trial comparing two protocols of oral care. Eur J Cancer 40: 1208-1216.
6. Cho KJ, Yun CH, Packer L, Chung AS (2001). Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Ann N Y Acad Sci 928: 141-156.
7. Clarkson JE, Worthington HV, Eden OB (2003). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 3: CD000978.
8. Worthington HV, Clarkson JE, Bryan G et al (2010). Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 8: CD000978.
9. Clinical Trials (PDQ®) National Cancer Institute at the National Institutes of Health (2011). Supersaturated calcium phosphate rinse in preventing oral mucositis in young patients undergoing autologous or donor stem cell transplant. Available at: http://www.cancer.gov/clinicaltrials/search/view/print?cdrid=695718&version=Patients& protocolsearchid=9780640 [assessed on 24 February 2011].
10. Dutta A, Dutta SK (2003). Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 22: 258-268.
11. Elad S, Ackerstein A, Bitan M et al (2006). A prospective, double- blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantations. Bone Marrow Transplant 37: 757-762.
12. El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA (2007). The effectiveness of vitamin E in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent 31: 167-170.
13. Grimm T, Schäfer A, Högger P (2004). Antioxidant activity and inhibition of matrix-metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol®). Free Radic Biol Med 36: 811-822.
14. Hejna M, Kostler WJ, Raderer M et al (2001). Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial. Eur J Cancer 37: 1994-2002.
15. Kostler WJ, Henja M, Wenzel C, Zielinski CC (2001). Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 51: 290-315.
16. Lalla RV, Sonis ST, Peterson DE (2008). Management of oral mucositis in patients with cancer. Dent Clin North Am 52: 61-68.
17. Lopez I, Goudou C, Ribrag V, Sauvage C, Hazebroucq G, Dreyfus F (1994). Treatment of mucositis with Vitamin E during administration of neutropenic antineoplastic agents. J Ann Med Interne 145: 405-408.
18. National Institutes of Health (1989). National Institutes of Health consensus development conference on oral complications of cancer therapies: diagnosis, prevention, and treatment. Bethesda, Maryland. NCI Monogr 9: 1-184.
19. Nieuwoudt CH (2011). Nutrition and the child with cancer: where do we stand and where do we need to go? S Afr J Clin Nutr 24: 23-26.
20. OliffH (2009). American botanical council proprietary botanical ingredient scientific and clinical monograph - pycnogenol®. American Botanical Council: Austin, TX.
21. Parulekar W, Mackenzie R, Bjarnason G, Jordan RCK (1998). Scoring oral mucositis. J Oral Oncol 34: 63-71.
22. van der Rijt CCD, Van Zuijlen L (2001). Studies on supportive care in oral mucositis: random or randomised?. Eur J Cancer 37: 1971-1975.
23. Rohdewald P (2002). A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40: 158-168.
24. Sime S, Reeve VE (2004). Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem Photobiol 79: 193-198.
25. Sonis ST (1998). Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34: 39-43.
26. Sonis ST (2004). The pathobiology of mucositis. Nat Rev Cancer 4: 279-284.
27. Sonis ST, Van Vugt AG, Brien JP et al (1997). Transforming growth factor-3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol 33: 47-54.
28. Sonis ST, Eilers JP, Epstein JB (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 85: 2103-2113.
29. Tomlinson D, Gibson F, Treister N et al (2009). Designing an oral mucositis assessment instrument for use in children: generating items using a nominal group technique. Support Care Cancer 17: 555-562.
30. Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies (2000). Available at: http://www.wipo.int/patentscope/search/en/WO2000002554 [accessed on 20 January 2000].
31. Wadleigh RG, Redman RS, Graham ML, Krasnow SH, Anderson A, Cohen MH (1992). Vitamin E in the treatment of chemotherapy- induced mucositis. Am J Med 92: 481-484.
32. World Health Organization (1979). WHO handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization, pp. 15-22.